About me
David Eavarone, PhD, Head of Lab and Screening, Absci. David has over a decade of experience leading the development of antibody-based therapeutics. He played a key role in engineering clinical-stage biologics against infectious disease targets at Visterra Inc and oncology targets at Siamab Therapeutics. More recently he has helped harness the power of AI for drug discovery, leading screening and characterization of AI-designed antibody libraries at Absci. He obtained his PhD in Biomedical Engineering at MIT through the Health Sciences and Technology program.